Key result
Cryo-EM reveals two leiomodin-2 molecules drive stepwise actin filament pointed-end elongation.
Why the study?
Leiomodin-2 was identified as a regulator proposed to promote actin thin filament pointed-end elongation, but its molecular mechanism remained unresolved.
Cryo-EM structures reveal how two leiomodin molecules cooperate to recruit actin subunits at the pointed end, providing a structural framework for understanding Lmod2 mutations in dilated cardiomyopathy.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for Lmod2 mutations in cardiomyopathy; extends the structural mechanism of pointed-end actin elongation.
In non-muscle cells, actin filaments exhibit variable lengths and rapid turnover, with subunits adding primarily at the barbed end. The situation is strikingly different in striated muscle sarcomeres, where despite rapid turnover, actin thin filaments exhibit uniform length and exchange subunits primarily at the pointed end. This filament length uniformity is tightly regulated by several proteins, including the molecular ruler nebulin in skeletal muscle and the barbed- and pointed-end capping proteins CapZ and tropomodulin (Tmod) in both skeletal and cardiac muscles. Recent studies in cells and animal models have identified leiomodin-2 (Lmod2) as an additional regulator proposed to promote pointed-end elongation to maintain thin filament length. This activity would make leiomodin the only known eukaryotic factor to drive pointed-end elongation, yet its molecular mechanism remains unresolved. Here, we present a series of cryo-electron microscopy structures that support a stepwise elongation mechanism in which two Lmod2 molecules alternate at the pointed end while recruiting actin monomers. These findings establish the molecular basis of pointed-end elongation in muscle sarcomeres and provide a framework for understanding mutations in Lmod2 that cause dilated cardiomyopathy. Here, cryo-EM structures reveal how two leiomodin molecules cooperate to recruit actin subunits at the pointed end and maintain uniform thin filament length in striated muscle sarcomeres.
No takes yet. Share an insight, caveat, or question.
Brotzman et al. (2026) studied this question. Leiomodin-2 (Lmod2) was evaluated on Cryo-EM structure of Lmod2 bound to actin filament pointed end. Cryo-EM structures reveal a stepwise elongation mechanism in which two leiomodin-2 molecules alternate at the pointed end of actin filaments while recruiting actin monomers.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: